# US 7,608,465 B2 · Multi-analyte diagnostic test for thyroid disorders > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 7,608,465 B2 - Document ID: US7608465B2 - Status: Granted - Kind: B2 - Application number: 10/243,145 - Filed: 2002-09-13 - Published: 2003-03-20 - Granted: 2009-10-27 - Earliest claimed: 1999-04-30 - Assignees: Bio-Rad Laboratories, Inc. - Inventors: Michael I. Watkins; Suknan S. Chang; Renato B. Del Rosario; Patricia A. Miranda; Timothy D. Knight; Richard B. Edwards - Web page: https://patentgrep.com/patent/US7608465B2 ## CPC - G01N 33/78: Thyroid gland hormones {, e.g. T3, T4, TBH, TBG or their receptors} - G01N 15/14: Optical investigation techniques, e.g. flow cytometry - Y10S 435/973: Simultaneous determination of more than one analyte - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) - Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ## Abstract Immunological assays for several biological markers for thyroid disorders in a biological sample are performed in a single test with a combination of sandwich-type, sequential competitive, and serological assays by the use of particles classified into groups that are distinguishable by flow cytometry, one group for the assay of each marker. Each group of particles is coated with a different immunological binding member, and coating densities, co-coating materials, and special buffer solutions are used to adjust for differences in the sensitivities and dynamic ranges of each of the markers in the typical sample. ## Claims ### Claim 1 A method for analyzing a single patient sample to simultaneously determine levels of thyroid stimulating hormone and thyroxine, said method comprising: (a) incubating said sample with a mixture of particles comprising magnetically responsive material in a first suspension, said mixture of particles comprised of groups (i) and (ii): (i) particles coated with anti-thyroid stimulating hormone, and (ii) particles coated with anti-thyroxine, the groups distinguishable from each other by a flow cytometry-distinguishable characteristic that is independent of the coatings of subparagraphs (i) and (ii); (b) recovering said particles from said first suspension by subjecting said suspension to a magnetic field to cause said particles to adhere to a reaction vessel wall, and incubating said recovered particles with a mixture of labeled binding members capable of binding to the recovered particles in a second suspension, said mixture of labeled binding members comprising: (1) labeled anti-thyroid stimulating hormone, and (2) a labeled analog toward which anti-thyroxine has immunological binding affinity, but in which said immunological binding affinity is less than that of anti-thyroxine toward thyroxine; and (c) recovering said particles from said second suspension by subjecting said suspension to a magnetic field to cause said particles to adhere to a reaction vessel wall and detecting the amount of label bound to said particles thus recovered while correlating by flow cytometry the amount of label thus detected to the group to which said label is bound, thereby simultaneously obtaining values individually representative of the levels of thyroid stimulating hormone and thyroxine. ### Claim 2 (depends on 1) A method in accordance with claim 1 in which said labeled binding members are binding members labeled with fluorescent labels. ### Claim 3 (depends on 2) A method in accordance with claim 2 in which said fluorescent labels are B-phycoerythrin. ### Claim 4 (depends on 1) A method in accordance with claim 1 in which said labeled binding members are labeled with a common label. ### Claim 5 (depends on 1) A method in accordance with claim 1 in which said particles include dyes, each of groups (i) and (ii) including a distinct dye that is distinguishable by flow cytometry over the dyes of each other group, and step (c) comprises distinguishing such dyes by flow cytometry while detecting the amount of label bound to said particles. ### Claim 6 (depends on 1) A method in accordance with claim 1 in which group (i) is comprised of two subgroups differing from each other by particle size such that one subgroup provides a substantially greater sensitivity for measuring lower concentrations of TSH, than the other. ### Claim 7 (depends on 6) A method according to claim 6 in which one group of particles provides a greater sensitivity for measuring lower concentrations of TSH than the other, and the second subgroup of particles provides a greater sensitivity for measuring higher concentrations of TSH than the other. ### Claim 8 (depends on 1) A method in accordance with claim 1 in which group (i) is comprised of two subgroups differing from each other by coating density of anti-thyroid stimulating hormone such that one subgroup provides a substantially greater sensitivity for measuring lower concentrations of TSH, than the other. ### Claim 9 (depends on 8) A method according to claim 8 in which one group of particles provides a greater sensitivity for measuring lower concentrations of TSH than the other, and the second subgroup of particles provides a greater sensitivity for measuring higher concentrations of TSH than the other. ### Claim 10 (depends on 1) A method in accordance with claim 1 in which group (i) is comprised of two subgroups differing from each other by both particle size and coating density of anti-thyroid stimulating hormone such that one subgroup provides a substantially greater sensitivity for measuring lower concentrations of TSH, than the other. ### Claim 11 (depends on 10) A method according to claim 10 in which one group of particles provides a greater sensitivity for measuring lower concentrations of TSH than the other, and the second subgroup of particles provides a greater sensitivity for measuring higher concentrations of TSH than the other.